Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3)
Brazil flag Brazil · Delayed Price · Currency is BRL
6.87
-0.19 (-2.69%)
May 13, 2026, 1:45 PM GMT-3

BVMF:PFRM3 Income Statement

Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11,61411,45110,1548,6627,8166,413
Revenue Growth (YoY)
9.43%12.77%17.22%10.82%21.88%17.00%
Cost of Revenue
9,8239,7008,6317,3706,6715,506
Gross Profit
1,7911,7501,5231,2921,146907.57
Selling, General & Admin
1,4021,3691,2251,046916.83668.28
Other Operating Expenses
32.0431.49-1.79-15.5-14.27-9.64
Operating Expenses
1,4341,4001,2231,031902.56771.32
Operating Income
356.93350.13299.65261.12242.95136.25
Interest Expense
-221.14-201.17-149.39-161.9-149.2-76.16
Interest & Investment Income
14.5314.538.310.958.684.9
Earnings From Equity Investments
-0.11-0.180.040.01-0.015.98
Other Non Operating Income (Expenses)
-40.17-45.85-30.74-28.59-23.46-10.71
EBT Excluding Unusual Items
110.04117.46127.8681.5978.9760.26
Impairment of Goodwill
------11.52
Pretax Income
110.04117.46127.8681.5978.9748.75
Income Tax Expense
-2.99-8.555.053.74-6.07-30.37
Earnings From Continuing Operations
113.03126.01122.8177.8685.0479.11
Minority Interest in Earnings
-7.55-7.12-8.23-7.46-4.17-0.92
Net Income
105.48118.9114.5870.480.8778.19
Net Income to Common
105.48118.9114.5870.480.8778.19
Net Income Growth
-15.31%3.77%62.76%-12.96%3.43%49.41%
Shares Outstanding (Basic)
123123123123123123
Shares Outstanding (Diluted)
123123123123123123
Shares Change (YoY)
0.40%-----
EPS (Basic)
0.860.970.930.570.660.64
EPS (Diluted)
0.860.970.930.570.660.64
EPS Growth
-15.60%3.82%62.72%-12.98%3.43%49.41%
Free Cash Flow
341.58312.98394.56193.3766.3739.04
Free Cash Flow Per Share
2.772.553.221.580.540.32
Dividend Per Share
--0.5750.3860.1730.271
Dividend Growth
--49.05%122.58%-35.94%-
Gross Margin
15.42%15.29%15.00%14.92%14.66%14.15%
Operating Margin
3.07%3.06%2.95%3.02%3.11%2.13%
Profit Margin
0.91%1.04%1.13%0.81%1.03%1.22%
Free Cash Flow Margin
2.94%2.73%3.89%2.23%0.85%0.61%
EBITDA
415.77404.46342.15295.65273.34162.72
EBITDA Margin
3.58%3.53%3.37%3.41%3.50%2.54%
D&A For EBITDA
58.8454.3342.534.5230.3826.47
EBIT
356.93350.13299.65261.12242.95136.25
EBIT Margin
3.07%3.06%2.95%3.02%3.11%2.13%
Effective Tax Rate
--3.95%4.58%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.